Lysosomal Disorders

Broadening Gene Therapy's Reach With Novel Capsids

LogicBio's Mariana Nacht, PhD, shares details of the company's novel capsid discovery platform and gene editing technology.

Mesenchymal Stem Cells Hold Promise for Osteoarthritis and More Chronic Diseases

Cynata Therapeutics' Ross Macdonald, PhD, discusses the company's pipeline and clinical-phase trials.

Cynata Therapeutics Takes Fresh Approach to Stem Cell Production

Ross Macdonald, PhD, managing director and CEO of Cynata Therapeutics, discusses the biotech company's approach to overcoming reproducibility challenges with mesenchymal stem cells.